{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:37:18Z","timestamp":1785541038167,"version":"3.56.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ard.2025.05.017","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T09:13:36Z","timestamp":1750238016000},"page":"186-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) definition of clinical remission in gout"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9906-7795","authenticated-orcid":false,"given":"Adwoa Dansoa","family":"Tabi-Amponsah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Stamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Terkeltaub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ard.2025.05.017_bib0001","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10067-015-3039-2","article-title":"\u201cYou want to get on with the rest of your life\u201d: a qualitative study of health-related quality of life in gout","volume":"35","author":"Chandratre","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.ard.2025.05.017_bib0002","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/acr.24475","article-title":"Gout flare severity from the patient perspective: a qualitative interview study","volume":"74","author":"Garcia-Guillen","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.ard.2025.05.017_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/RHU.0b013e318204a8f9","article-title":"The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach","volume":"17","author":"Lindsay","year":"2011","journal-title":"J Clin Rheumatol"},{"issue":"Suppl 2","key":"10.1016\/j.ard.2025.05.017_bib0004","doi-asserted-by":"crossref","first-page":"i86","DOI":"10.1136\/annrheumdis-2011-200618","article-title":"Defining remission in rheumatoid arthritis","volume":"71","author":"Felson","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ard.2025.05.017_bib0005","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3899\/jrheum.090370","article-title":"Outcome domains for studies of acute and chronic gout","volume":"36","author":"Schumacher","year":"2009","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.ard.2025.05.017_bib0006","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/acr.22741","article-title":"Development of preliminary remission criteria for gout using Delphi and 1000Minds consensus exercises","volume":"68","author":"de Lautour","year":"2016","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"8","key":"10.1016\/j.ard.2025.05.017_bib0007","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/acr2.11579","article-title":"The patient experience of gout remission: a qualitative study","volume":"5","author":"Tabi-Amponsah","year":"2023","journal-title":"ACR Open Rheumatol"},{"issue":"3","key":"10.1016\/j.ard.2025.05.017_bib0008","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/acr.23607","article-title":"Gout, Hyperuricemia, and Crystal-Associated Disease Network consensus statement regarding labels and definitions for disease elements in gout","volume":"71","author":"Bursill","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ard.2025.05.017_bib0009","unstructured":"About G-CAN 2024. Available from: https:\/\/www.g-can.org\/mission-statement\/. Accessed May 9, 2025."},{"issue":"12","key":"10.1016\/j.ard.2025.05.017_bib0010","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/acr.25414","article-title":"Baseline dual-energy computed tomography urate volume predicts fulfillment of gout remission after two years of urate-lowering therapy","volume":"76","author":"Tabi-Amponsah","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1016\/j.ard.2025.05.017_bib0011","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3899\/jrheum.2024-0400","article-title":"Analysis of gout remission definitions in a randomized controlled trial of colchicine prophylaxis for people with gout initiating allopurinol","volume":"51","author":"Tabi-Amponsah","year":"2024","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ard.2025.05.017_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152555","article-title":"Post-hoc analysis of two gout remission definitions in a two-year randomized controlled trial of nurse-led versus usual gout care","volume":"69","author":"Tabi-Amponsah","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ard.2025.05.017_bib0013","unstructured":"Tabi-Amponsah AD, Stewart S, Gamble G, et al. Time trends and predictors of gout remission over six years: a post hoc analysis of the CARES trial [Manuscript submitted for publication]. Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland."},{"issue":"6","key":"10.1016\/j.ard.2025.05.017_bib0014","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/art.42055","article-title":"Intensive serum urate lowering with oral urate-lowering therapy for erosive gout: a randomized double-blind controlled trial","volume":"74","author":"Dalbeth","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ard.2025.05.017_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/ard-2023-224731","article-title":"Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial","author":"Stamp","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"10156","key":"10.1016\/j.ard.2025.05.017_bib0016","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","article-title":"Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial","volume":"392","author":"Doherty","year":"2018","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.ard.2025.05.017_bib0017","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular safety of febuxostat or allopurinol in patients with gout","volume":"378","author":"White","year":"2018","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.ard.2025.05.017_bib0018","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ard.2025.05.017_bib0019","series-title":"OMERACT handbook: instrument selection for core outcome measurement sets","author":"Beaton","year":"2021"},{"issue":"6","key":"10.1016\/j.ard.2025.05.017_bib0020","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jpsychores.2005.10.020","article-title":"The brief illness perception questionnaire","volume":"60","author":"Broadbent","year":"2006","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.ard.2025.05.017_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/PROM.S8310","article-title":"Gout disease-specific quality of life and the association with gout characteristics","volume":"2010","author":"Hirsch","year":"2010","journal-title":"Patient Relat Outcome Meas"},{"key":"10.1016\/j.ard.2025.05.017_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152191","article-title":"Outcome reporting in randomized trials in gout: a systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set","volume":"60","author":"Morillon","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.ard.2025.05.017_bib0023","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/art.40381","article-title":"Brief report: validation of a definition of flare in patients with established gout","volume":"70","author":"Gaffo","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ard.2025.05.017_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2025.152698","article-title":"Remission in gout is possible: 5-year follow-up in the NOR-Gout study","volume":"72","author":"Uhlig","year":"2025","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ard.2025.05.017_bib0025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13075-019-1941-8","article-title":"Concurrent validity of provisional remission criteria for gout: a dual-energy CT study","volume":"21","author":"Dalbeth","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.ard.2025.05.017_bib0026","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13075-021-02568-x","article-title":"Sonographic estimation of monosodium urate burden predicts the fulfillment of the 2016 remission criteria for gout: a 12-month study","volume":"23","author":"Cipolletta","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.ard.2025.05.017_bib0027","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1136\/annrheumdis-2019-215933","article-title":"Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout","volume":"78","author":"Bursill","year":"2019","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725010271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725010271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:21:52Z","timestamp":1769826112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496725010271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0003496725010271"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.05.017","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) definition of clinical remission in gout","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Alliance of Associations for Rheumatology (EULAR). Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}